• Home
  • About Us
    • Overview
  • Research
    • Asbestos Voices: Defining Research Priorities
    • Biobank/Biomarkers
    • Bioinformatics/Systems Biology
    • Genomics Sequencing
    • Imaging: Human & Mouse
    • Mouse Models
    • Novel Therapies
    • Tumour Immunology
  • News and Resources
    • Patient and Family Information
    • Clinical Trials
    • Asbestos Review Program
    • NCARD Publications
    • News
  • Study With Us
    • Alumni
  • Contact Us
DONATE
  • Home
  • About Us
    • Overview
  • Research
    • Asbestos Voices: Defining Research Priorities
    • Biobank/Biomarkers
    • Bioinformatics/Systems Biology
    • Genomics Sequencing
    • Imaging: Human & Mouse
    • Mouse Models
    • Novel Therapies
    • Tumour Immunology
  • News and Resources
    • Patient and Family Information
    • Clinical Trials
    • Asbestos Review Program
    • NCARD Publications
    • News
  • Study With Us
    • Alumni
  • Contact Us

NCARD Secures Funding for Innovative Mesothelioma Imaging Study

News
1 year ago
NCARD secures funding for Innovative Mesothelioma Imaging study feature image
The National Centre for Asbestos Related Diseases (NCARD) has been awarded $200,000 from the Medical Research Future Fund (MRFF) to support a new imaging trial for mesothelioma, an asbestos-related cancer.…

NCARD secures $500K for international mesothelioma research consortium

News
1 year ago
The National Centre for Asbestos Related Diseases (NCARD) has been awarded a substantial grant of $500,000 to establish the Mesothelioma AI Genomics and Immunology Consortium (MAGIC). Led by Professor Jenette…

NCARD at iMig 2025: Advancing global collaboration in mesothelioma research

Event, News
1 year ago
IMIG 2025 Feature Image 2
The 17th International Conference of the International Mesothelioma Interest Group (iMig) will be held in Philadelphia, USA, from October 26 to 29, 2025. With the theme ‘Fostering Global Collaboration,’ this…

NCARD scientist awarded translation fellowship for innovative mesothelioma research

News
2 years ago
Jon FHRI feature image
Dr Jonathan Chee, a researcher at the National Centre for Asbestos Related Diseases (NCARD), within the University of Western Australia and the Institute of Respiratory Health, has been awarded a…

NCARD expands expertise to transform childhood cancer treatment

News
2 years ago
NCARD expands expertise to transform childhood cancer treatment
The National Centre for Asbestos Related Diseases (NCARD) is bringing its internationally recognised expertise in cancer immunotherapy to improve outcomes for children with cancer. In collaboration with Perth Children’s Hospital…
National Centre for Asbestos Related Diseases

NCARD researchers are recognised as world leaders. We have an extensive collaborative network with leading researchers across the globe.

NCARD is part of the University of Western Australia (UWA) and Institute for Respiratory Health (IRH).

Latest News

Recent Posts

  • NCARD researcher awarded $100,000 to investigate ways to improved cancer immunotherapy August 13, 2026
  • Public invite to NCARD lecture on asbestos risk, research and care August 12, 2026
  • Australians affected by asbestos asked what researchers should study next July 15, 2026
  • Australia’s lung cancer screening program is a year old. But can the health system deliver? July 10, 2026
Scientific Publications

NCARD researchers have published hundreds of peer-reviewed articles on mesothelioma and related research. Visit our Scientific Publications page to see papers from the last several years.

Subscribe

Keep in touch by subscribing to the NCARD newsletter.

Contacts
ncard-research@uwa.edu.au
(08) 6151 1078

QQ Block
QEII Medical Campus
6 Verdun Street
Nedlands
6009

Designed by Redhead Digital Marketing